It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
QIPT’s FA Score shows that 1 FA rating(s) are green whileRVTY’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
QIPT’s TA Score shows that 5 TA indicator(s) are bullish while RVTY’s TA Score has 4 bullish TA indicator(s).
QIPT (@Medical Distributors) experienced а -7.79% price change this week, while RVTY (@Medical Specialties) price change was -1.58% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was -1.62%. For the same industry, the average monthly price growth was +4.99%, and the average quarterly price growth was +1.45%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +4.25%. For the same industry, the average monthly price growth was +1.87%, and the average quarterly price growth was -1.45%.
QIPT is expected to report earnings on Dec 22, 2025.
RVTY is expected to report earnings on Nov 04, 2025.
Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
@Medical Specialties (+4.25% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
QIPT | RVTY | QIPT / RVTY | |
Capitalization | 93M | 10.1B | 1% |
EBITDA | 49.2M | N/A | - |
Gain YTD | -30.164 | -22.032 | 137% |
P/E Ratio | N/A | 37.76 | - |
Revenue | 241M | N/A | - |
Total Cash | 17.1M | N/A | - |
Total Debt | 98.3M | 3.33B | 3% |
QIPT | RVTY | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | 57 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 86 | |
PRICE GROWTH RATING 1..100 | 61 | 64 | |
P/E GROWTH RATING 1..100 | 3 | 94 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RVTY's Valuation (57) in the Medical Specialties industry is somewhat better than the same rating for QIPT (94) in the null industry. This means that RVTY’s stock grew somewhat faster than QIPT’s over the last 12 months.
RVTY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as QIPT (100) in the null industry. This means that RVTY’s stock grew similarly to QIPT’s over the last 12 months.
RVTY's SMR Rating (86) in the Medical Specialties industry is in the same range as QIPT (94) in the null industry. This means that RVTY’s stock grew similarly to QIPT’s over the last 12 months.
QIPT's Price Growth Rating (61) in the null industry is in the same range as RVTY (64) in the Medical Specialties industry. This means that QIPT’s stock grew similarly to RVTY’s over the last 12 months.
QIPT's P/E Growth Rating (3) in the null industry is significantly better than the same rating for RVTY (94) in the Medical Specialties industry. This means that QIPT’s stock grew significantly faster than RVTY’s over the last 12 months.
QIPT | RVTY | |
---|---|---|
RSI ODDS (%) | 4 days ago84% | N/A |
Stochastic ODDS (%) | 4 days ago74% | 4 days ago71% |
Momentum ODDS (%) | 4 days ago83% | 4 days ago69% |
MACD ODDS (%) | 4 days ago89% | 4 days ago72% |
TrendWeek ODDS (%) | 4 days ago80% | 4 days ago64% |
TrendMonth ODDS (%) | 4 days ago75% | 4 days ago67% |
Advances ODDS (%) | 11 days ago73% | 4 days ago68% |
Declines ODDS (%) | 4 days ago81% | 12 days ago65% |
BollingerBands ODDS (%) | 4 days ago77% | 4 days ago66% |
Aroon ODDS (%) | 4 days ago72% | 4 days ago65% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPUS | 46.65 | 0.37 | +0.80% |
SP Funds S&P 500 Sharia Industry Ex ETF | |||
IPAV | 27.81 | 0.12 | +0.44% |
Global X Infrastructure Dev ex-U.S. ETF | |||
BSJT | 21.48 | 0.03 | +0.15% |
Invesco BulletShares 2029 HY Corp Bd ETF | |||
FDTS | 52.94 | N/A | N/A |
First Trust DevMkts exUS SC AlphaDEX®ETF | |||
SBIO | 32.74 | -0.04 | -0.13% |
ALPS Medical Breakthroughs ETF |
A.I.dvisor tells us that QIPT and TMO have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QIPT and TMO's prices will move in lockstep.
Ticker / NAME | Correlation To QIPT | 1D Price Change % | ||
---|---|---|---|---|
QIPT | 100% | -0.47% | ||
TMO - QIPT | 32% Poorly correlated | +1.32% | ||
QDEL - QIPT | 31% Poorly correlated | -2.01% | ||
RVTY - QIPT | 30% Poorly correlated | +0.44% | ||
BIO - QIPT | 28% Poorly correlated | -0.40% | ||
AVNS - QIPT | 28% Poorly correlated | +0.74% | ||
More |
A.I.dvisor indicates that over the last year, RVTY has been closely correlated with MTD. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVTY jumps, then MTD could also see price increases.
Ticker / NAME | Correlation To RVTY | 1D Price Change % | ||
---|---|---|---|---|
RVTY | 100% | +0.44% | ||
MTD - RVTY | 81% Closely correlated | +1.54% | ||
A - RVTY | 80% Closely correlated | +0.56% | ||
TMO - RVTY | 77% Closely correlated | +1.32% | ||
WAT - RVTY | 72% Closely correlated | +1.15% | ||
DHR - RVTY | 72% Closely correlated | +1.04% | ||
More |